165 related articles for article (PubMed ID: 25633211)
21. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
[TBL] [Abstract][Full Text] [Related]
22. Current Phase II drugs under investigation for the treatment of limb ischemia.
Spiliopoulos S; Kitrou P; Katsanos K; Karnabatidis D
Expert Opin Investig Drugs; 2015; 24(11):1447-58. PubMed ID: 26296189
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte Growth Factor Gene Therapy for Ischemic Diseases.
Wang LS; Wang H; Zhang QL; Yang ZJ; Kong FX; Wu CT
Hum Gene Ther; 2018 Apr; 29(4):413-423. PubMed ID: 29409352
[TBL] [Abstract][Full Text] [Related]
24. Regenerative medicine in critical limb ischemia.
Ohno T; Kaneda H; Nagai Y; Fukushima M
J Atheroscler Thromb; 2012; 19(10):883-9. PubMed ID: 22785564
[TBL] [Abstract][Full Text] [Related]
25. Modulating the vascular response to limb ischemia: angiogenic and cell therapies.
Cooke JP; Losordo DW
Circ Res; 2015 Apr; 116(9):1561-78. PubMed ID: 25908729
[TBL] [Abstract][Full Text] [Related]
26. pUDK-HGF Gene Therapy to Relieve CLI Rest Pain and Ulcer: A Phase II, Double-Blind, Randomized Placebo-Controlled Trial.
Gu Y; Cui S; Liu C; Zhao J; Li M; Li Y; Yang X; Lv B; Li M; Zhao W; Guo W; Huang J; Huang W; Qiu Z; Zhao J; Yin P; Qin T; Zhu D; Sun W; Ren K; Lu Y; Cheng X; Du L; Xiao F; Zhang Q; Wu Z
Hum Gene Ther; 2021 Aug; 32(15-16):839-849. PubMed ID: 33726499
[TBL] [Abstract][Full Text] [Related]
27. Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease.
Niebuhr A; Henry T; Goldman J; Baumgartner I; van Belle E; Gerss J; Hirsch AT; Nikol S
Gene Ther; 2012 Mar; 19(3):264-70. PubMed ID: 21716303
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
29. A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia.
Gu Y; Zhang J; Guo L; Cui S; Li X; Ding D; Kim JM; Ho SH; Hahn W; Kim S
J Gene Med; 2011 Nov; 13(11):602-10. PubMed ID: 22015632
[TBL] [Abstract][Full Text] [Related]
30. Review of the Current Basic Science Strategies to Treat Critical Limb Ischemia.
Haghighat L; Ionescu CN; Regan CJ; Altin SE; Attaran RR; Mena-Hurtado CI
Vasc Endovascular Surg; 2019 May; 53(4):316-324. PubMed ID: 30808262
[TBL] [Abstract][Full Text] [Related]
31. Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.
Henry TD; Hirsch AT; Goldman J; Wang YL; Lips DL; McMillan WD; Duval S; Biggs TA; Keo HH
Gene Ther; 2011 Aug; 18(8):788-94. PubMed ID: 21430785
[TBL] [Abstract][Full Text] [Related]
32. FGF-4 gene therapy GENERX--Collateral Therapeutics.
BioDrugs; 2002; 16(1):75-6. PubMed ID: 11909005
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic angiogenesis for critical limb ischemia.
Ko SH; Bandyk DF
Semin Vasc Surg; 2014 Mar; 27(1):23-31. PubMed ID: 25812756
[TBL] [Abstract][Full Text] [Related]
34. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia.
Shigematsu H; Yasuda K; Iwai T; Sasajima T; Ishimaru S; Ohashi Y; Yamaguchi T; Ogihara T; Morishita R
Gene Ther; 2010 Sep; 17(9):1152-61. PubMed ID: 20393508
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte growth factor as potential cardiovascular therapy.
Nakagami H; Kaneda Y; Ogihara T; Morishita R
Expert Rev Cardiovasc Ther; 2005 May; 3(3):513-9. PubMed ID: 15889978
[TBL] [Abstract][Full Text] [Related]
37. [Intramuscular injection of lentivirus-mediated EPAS1 gene improves hind limb ischemia and its mechanism in a rat model of peripheral artery vascular disease].
Wang Z; Gu H; Yang F; Xie H; Sheng L; Li M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1539-1543. PubMed ID: 29268860
[TBL] [Abstract][Full Text] [Related]
38. Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101.
Matsumoto T; Tanaka M; Yoshiya K; Yoshiga R; Matsubara Y; Horiuchi-Yoshida K; Yonemitsu Y; Maehara Y
Sci Rep; 2016 Jul; 6():30035. PubMed ID: 27418463
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up evaluation of results from clinical trial using hepatocyte growth factor gene to treat severe peripheral arterial disease.
Makino H; Aoki M; Hashiya N; Yamasaki K; Azuma J; Sawa Y; Kaneda Y; Ogihara T; Morishita R
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2503-9. PubMed ID: 22904270
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy in the treatment of peripheral arterial disease.
Mughal NA; Russell DA; Ponnambalam S; Homer-Vanniasinkam S
Br J Surg; 2012 Jan; 99(1):6-15. PubMed ID: 22068822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
